Apple, Inc AAPL
S&P 500 ETF Trust SPDR SPY
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

BridgeBio Oncology Therapeutics, Inc., Common Stock

BBOT

NMQ

$8.94

-$0.51

(-5.4%)

Analyst Forecast

Overview Returns Financials Ratios News FAQs

Price Chart

Key Metrics

Market Cap info-icon

This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.

$748.41M

P/E Ratio

This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.

Volume

This is the total number of shares traded during the most recent trading day.

244.89K

Avg Volume info-icon

This is the average number of shares traded during the most recent 30 days.

Dividend Yield info-icon

This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).

0.00%

Beta

This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.

52-week Range
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

$8.7 L

$12.5 H

$8.94

About BridgeBio Oncology Therapeutics, Inc., Common Stock

BridgeBio Oncology Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of small molecule inhibitor for cancer patients. The company is based in South San Francisco, California. BridgeBio Oncology Therapeutics, Inc. operates as a subsidiary of BridgeBio Pharma, Inc. more

Returns

Data is not properly formatted.

Time Frame	BBOT		S&P500
1-Week Return	1.13%%	%	0.56%%
1-Month Return	-10.6%%	%	2.16%%

Financials

	Dec '23	Dec '24
Total Revenue	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Profit	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Margin	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Operating Expenses	64.77M	80.86M	[{"date":"2023-12-31","value":80.1,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income	(64.77M)	(80.86M)	[{"date":"2023-12-31","value":-6477100000,"profit":false},{"date":"2024-12-31","value":-8086300000,"profit":false}]
Total Non-Operating Income/Expense	-	6.59M	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income	(64.70M)	(74.28M)	[{"date":"2023-12-31","value":-6469900000,"profit":false},{"date":"2024-12-31","value":-7427500000,"profit":false}]
Income Taxes	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Income From Continuous Operations	(64.70M)	(74.28M)	[{"date":"2023-12-31","value":-6469900000,"profit":false},{"date":"2024-12-31","value":-7427500000,"profit":false}]
Income From Discontinued Operations	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income	(64.70M)	(74.28M)	[{"date":"2023-12-31","value":-6469900000,"profit":false},{"date":"2024-12-31","value":-7427500000,"profit":false}]

EPS (Diluted)	-	0.32	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]

	Dec '23	Dec '24
Total Revenue	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Profit	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Margin	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Operating Expenses	-	24.84%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income	-	24.84%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Non-Operating Income/Expense	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Pre-Tax Income	-	14.80%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Income Taxes	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Income From Continuous Operations	-	14.80%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Income From Discontinued Operations	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income	-	14.80%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]

EPS (Diluted)	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

	Mar '24	Jun '24	Mar '25	Jun '25
Total Revenue	-	-	-	-	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true}]
Cost of Revenue	-	-	-	-	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true}]
Gross Profit	-	-	-	-	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true}]
Gross Margin	-	-	-	-	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true}]

Operating Expenses	15.45M	23.87M	23.14M	30.09M	[{"date":"2024-03-31","value":51.34,"profit":true},{"date":"2024-06-30","value":79.32,"profit":true},{"date":"2025-03-31","value":76.88,"profit":true},{"date":"2025-06-30","value":100,"profit":true}]
Operating Income	(15.45M)	(23.87M)	(23.14M)	(30.09M)	[{"date":"2024-03-31","value":-1544900000,"profit":false},{"date":"2024-06-30","value":-2387100000,"profit":false},{"date":"2025-03-31","value":-2313700000,"profit":false},{"date":"2025-06-30","value":-3009300000,"profit":false}]
Total Non-Operating Income/Expense	7.00K	2.05M	1.08M	1.66M	[{"date":"2024-03-31","value":0.34,"profit":true},{"date":"2024-06-30","value":100,"profit":true},{"date":"2025-03-31","value":52.83,"profit":true},{"date":"2025-06-30","value":80.96,"profit":true}]
Pre-Tax Income	(15.44M)	(21.82M)	(22.05M)	(28.43M)	[{"date":"2024-03-31","value":-1544200000,"profit":false},{"date":"2024-06-30","value":-2182300000,"profit":false},{"date":"2025-03-31","value":-2205500000,"profit":false},{"date":"2025-06-30","value":-2843500000,"profit":false}]
Income Taxes	-	-	-	-	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true}]
Income After Taxes	-	-	-	-	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true}]

Income From Continuous Operations	(15.44M)	(21.82M)	(22.05M)	(28.43M)	[{"date":"2024-03-31","value":-1544200000,"profit":false},{"date":"2024-06-30","value":-2182300000,"profit":false},{"date":"2025-03-31","value":-2205500000,"profit":false},{"date":"2025-06-30","value":-2843500000,"profit":false}]
Income From Discontinued Operations	-	-	-	-	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true}]
Net Income	(15.44M)	(21.82M)	(22.05M)	(28.43M)	[{"date":"2024-03-31","value":-1544200000,"profit":false},{"date":"2024-06-30","value":-2182300000,"profit":false},{"date":"2025-03-31","value":-2205500000,"profit":false},{"date":"2025-06-30","value":-2843500000,"profit":false}]

EPS (Diluted)	0.05	0.09	(0.02)	0.04	[{"date":"2024-03-31","value":49.73,"profit":true},{"date":"2024-06-30","value":100,"profit":true},{"date":"2025-03-31","value":-22,"profit":false},{"date":"2025-06-30","value":41.55,"profit":true}]

	Mar '24	Jun '24	Mar '25	Jun '25
Total Revenue	-	-	-	-	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true}]
Cost of Revenue	-	-	-	-	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true}]
Gross Profit	-	-	-	-	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true}]
Gross Margin	-	-	-	-	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true}]

Operating Expenses	-	54.51%	(3.07%)	30.06%	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":100,"profit":true},{"date":"2025-03-31","value":-5.64,"profit":false},{"date":"2025-06-30","value":55.15,"profit":true}]
Operating Income	-	54.51%	(3.07%)	30.06%	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":100,"profit":true},{"date":"2025-03-31","value":-5.64,"profit":false},{"date":"2025-06-30","value":55.15,"profit":true}]
Total Non-Operating Income/Expense	-	29157.14%	(47.17%)	53.23%	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":100,"profit":true},{"date":"2025-03-31","value":-0.16,"profit":false},{"date":"2025-06-30","value":0.18,"profit":true}]
Pre-Tax Income	-	41.32%	1.06%	28.93%	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":100,"profit":true},{"date":"2025-03-31","value":2.57,"profit":true},{"date":"2025-06-30","value":70,"profit":true}]
Income Taxes	-	-	-	-	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true}]
Income After Taxes	-	-	-	-	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true}]

Income From Continuous Operations	-	41.32%	1.06%	28.93%	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":100,"profit":true},{"date":"2025-03-31","value":2.57,"profit":true},{"date":"2025-06-30","value":70,"profit":true}]
Income From Discontinued Operations	-	-	-	-	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true}]
Net Income	-	41.32%	1.06%	28.93%	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":100,"profit":true},{"date":"2025-03-31","value":2.57,"profit":true},{"date":"2025-06-30","value":70,"profit":true}]

EPS (Diluted)	-	101.07%	(122.00%)	(288.89%)	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":100,"profit":true},{"date":"2025-03-31","value":-120.71,"profit":false},{"date":"2025-06-30","value":-285.84,"profit":false}]

	Dec '23	Dec '24
Total Assets
Current Assets	3.94M	158.69M	[{"date":"2023-12-31","value":2.48,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Non-current Assets	2.00M	5.61M	[{"date":"2023-12-31","value":35.75,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Assets	5.94M	164.30M	[{"date":"2023-12-31","value":3.62,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Total Liabilities
Current Liabilities	16.77M	19.58M	[{"date":"2023-12-31","value":85.67,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Non-current Liabilities	104.81M	323.36M	[{"date":"2023-12-31","value":32.41,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Liabilities	121.58M	342.94M	[{"date":"2023-12-31","value":35.45,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Retained Earnings	(148.25M)	(222.52M)	[{"date":"2023-12-31","value":-14824800000,"profit":false},{"date":"2024-12-31","value":-22252300000,"profit":false}]
Other Stockholders' Equity	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Total Shareholders' equity	(115.64M)	(178.64M)	[{"date":"2023-12-31","value":-11564100000,"profit":false},{"date":"2024-12-31","value":-17863700000,"profit":false}]

Total Liabilities & Shareholders Equity	5.94M	164.30M	[{"date":"2023-12-31","value":3.62,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

	Dec '23	Dec '24
Total Assets
Current Assets	-	3930.81%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Non-current Assets	-	179.70%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Assets	-	2665.08%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Total Liabilities
Current Liabilities	-	16.72%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Non-current Liabilities	-	208.52%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Liabilities	-	182.06%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Retained Earnings	-	50.10%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Other Stockholders' Equity	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Total Shareholders' equity	-	54.48%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	-	2665.08%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]

	Mar '25	Jun '25
Total Assets
Current Assets	141.33M	142.35M	[{"date":"2025-03-31","value":99.28,"profit":true},{"date":"2025-06-30","value":100,"profit":true}]
Non-current Assets	8.51M	8.91M	[{"date":"2025-03-31","value":95.52,"profit":true},{"date":"2025-06-30","value":100,"profit":true}]
Total Assets	149.84M	151.25M	[{"date":"2025-03-31","value":99.06,"profit":true},{"date":"2025-06-30","value":100,"profit":true}]

Total Liabilities
Current Liabilities	24.06M	27.25M	[{"date":"2025-03-31","value":88.28,"profit":true},{"date":"2025-06-30","value":100,"profit":true}]
Non-current Liabilities	325.81M	351.74M	[{"date":"2025-03-31","value":92.63,"profit":true},{"date":"2025-06-30","value":100,"profit":true}]
Total Liabilities	349.87M	378.99M	[{"date":"2025-03-31","value":92.32,"profit":true},{"date":"2025-06-30","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	[{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true}]
Retained Earnings	(244.58M)	(273.01M)	[{"date":"2025-03-31","value":-24457800000,"profit":false},{"date":"2025-06-30","value":-27301300000,"profit":false}]
Other Stockholders' Equity	-	-	[{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true}]
Total Shareholders' equity	(200.03M)	(227.73M)	[{"date":"2025-03-31","value":-20003300000,"profit":false},{"date":"2025-06-30","value":-22773300000,"profit":false}]

Total Liabilities & Shareholders Equity	149.84M	151.25M	[{"date":"2025-03-31","value":99.06,"profit":true},{"date":"2025-06-30","value":100,"profit":true}]

	Mar '25	Jun '25
Total Assets
Current Assets	-	0.72%	[{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":100,"profit":true}]
Non-current Assets	-	4.69%	[{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":100,"profit":true}]
Total Assets	-	0.95%	[{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":100,"profit":true}]

Total Liabilities
Current Liabilities	-	13.28%	[{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":100,"profit":true}]
Non-current Liabilities	-	7.96%	[{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":100,"profit":true}]
Total Liabilities	-	8.32%	[{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	[{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true}]
Retained Earnings	-	11.63%	[{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":100,"profit":true}]
Other Stockholders' Equity	-	-	[{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true}]
Total Shareholders' equity	-	13.85%	[{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	-	0.95%	[{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":100,"profit":true}]

	Dec '23	Dec '24
Operating Activities
Net Operating Cash Flow	(52.08M)	(55.03M)	[{"date":"2023-12-31","value":-5207900000,"profit":false},{"date":"2024-12-31","value":-5502700000,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	55.12M	206.29M	[{"date":"2023-12-31","value":26.72,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Net Change in Cash	225.00K	30.73M	[{"date":"2023-12-31","value":0.73,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Free Cash Flow
Free Cash Flow	(52.49M)	(55.08M)	[{"date":"2023-12-31","value":-5249300000,"profit":false},{"date":"2024-12-31","value":-5507600000,"profit":false}]

	Dec '23	Dec '24
Operating Activities
Net Operating Cash Flow	-	5.66%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Investing Activities
Net Investing Cash Flow	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	-	274.23%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Net Change in Cash	-	13559.11%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Free Cash Flow
Free Cash Flow	-	4.92%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]

	Mar '24	Jun '24	Mar '25	Jun '25
Operating Activities
Net Operating Cash Flow	(8.87M)	(8.15M)	(19.60M)	(23.29M)	[{"date":"2024-03-31","value":-886500000,"profit":false},{"date":"2024-06-30","value":-815500000,"profit":false},{"date":"2025-03-31","value":-1959900000,"profit":false},{"date":"2025-06-30","value":-2329300000,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	-	-	-	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	6.65M	199.59M	(404.00K)	18.96M	[{"date":"2024-03-31","value":3.33,"profit":true},{"date":"2024-06-30","value":100,"profit":true},{"date":"2025-03-31","value":-0.2,"profit":false},{"date":"2025-06-30","value":9.5,"profit":true}]

Net Change in Cash	174.00K	39.93M	(4.63M)	5.30M	[{"date":"2024-03-31","value":0.44,"profit":true},{"date":"2024-06-30","value":100,"profit":true},{"date":"2025-03-31","value":-11.61,"profit":false},{"date":"2025-06-30","value":13.28,"profit":true}]

Free Cash Flow
Free Cash Flow	(8.88M)	(8.17M)	(19.76M)	(23.52M)	[{"date":"2024-03-31","value":-887900000,"profit":false},{"date":"2024-06-30","value":-816900000,"profit":false},{"date":"2025-03-31","value":-1976100000,"profit":false},{"date":"2025-06-30","value":-2352400000,"profit":false}]

	Mar '24	Jun '24	Mar '25	Jun '25
Operating Activities
Net Operating Cash Flow	-	(8.01%)	140.33%	18.85%	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":-5.71,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":13.43,"profit":true}]

Investing Activities
Net Investing Cash Flow	-	-	-	-	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	-	2902.72%	(100.20%)	(4792.08%)	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":100,"profit":true},{"date":"2025-03-31","value":-3.45,"profit":false},{"date":"2025-06-30","value":-165.09,"profit":false}]

Net Change in Cash	-	22850.57%	(111.61%)	(214.39%)	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":100,"profit":true},{"date":"2025-03-31","value":-0.49,"profit":false},{"date":"2025-06-30","value":-0.94,"profit":false}]

Free Cash Flow
Free Cash Flow	-	(8.00%)	141.90%	19.04%	[{"date":"2024-03-31","value":"-","profit":true},{"date":"2024-06-30","value":-5.64,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":13.42,"profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

	BBOT
Current Ratio	5.22

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

	BBOT
ROA (LTM)	0.00%
ROE (LTM)	0.00%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

	BBOT
Debt Ratio Lower is generally better. Negative is bad.	2.51
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier.	-1.51

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

	BBOT
Trailing PE	NM
Forward PE	NM
P/S (TTM)	0.00
P/B	0.00
EV/R	0.00
EV/Ebitda	NM

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

What is BridgeBio Oncology Therapeutics, Inc. share price today?

BridgeBio Oncology Therapeutics, Inc. (BBOT) share price today is $8.94

Can Indians buy BridgeBio Oncology Therapeutics, Inc. shares?

Yes, Indians can buy shares of BridgeBio Oncology Therapeutics, Inc. (BBOT) on Vested. To buy BridgeBio Oncology Therapeutics, Inc. from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in BBOT stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of BridgeBio Oncology Therapeutics, Inc. be purchased?

Yes, you can purchase fractional shares of BridgeBio Oncology Therapeutics, Inc. (BBOT) via the Vested app. You can start investing in BridgeBio Oncology Therapeutics, Inc. (BBOT) with a minimum investment of $1.

How to invest in BridgeBio Oncology Therapeutics, Inc. shares from India?

You can invest in shares of BridgeBio Oncology Therapeutics, Inc. (BBOT) via Vested in three simple steps:

Click on Sign Up or Invest in BBOT stock at the top of this page
Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
Transfer USD funds to your US Brokerage account and start investing in BridgeBio Oncology Therapeutics, Inc. shares

What is BridgeBio Oncology Therapeutics, Inc. 52-week high and low stock price?

The 52-week high price of BridgeBio Oncology Therapeutics, Inc. (BBOT) is $12.5. The 52-week low price of BridgeBio Oncology Therapeutics, Inc. (BBOT) is $8.7.

What is BridgeBio Oncology Therapeutics, Inc. price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of BridgeBio Oncology Therapeutics, Inc. (BBOT) is 0.00

What is the Market Cap of BridgeBio Oncology Therapeutics, Inc.?

The market capitalization of BridgeBio Oncology Therapeutics, Inc. (BBOT) is $748.41M

What is BridgeBio Oncology Therapeutics, Inc.’s stock symbol?

The stock symbol (or ticker) of BridgeBio Oncology Therapeutics, Inc. is BBOT

Feedback

Request to add more info/data

Inform about wrong info/data

Link copied

Signup to access all features and start your US investing journey!

Open your account in minutes
Take your portfolio global, starting at just $1

Get started

Add ticker to compare

Apple, Inc AAPL
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

US Stocks & ETFs

Private Markets Private Beta

Managed Portfolios (Previously Vests)

Global Mutual Funds Join Waitlist

Global

India

Explore our India Diversification

INR Bonds

Alt FDs

BridgeBio Oncology Therapeutics, Inc., Common Stock

BBOT

NMQ

$8.94

-$0.51

(-5.4%)

Analyst Forecast

Price Chart

Key Metrics

52-week Range This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

About BridgeBio Oncology Therapeutics, Inc., Common Stock

Returns

Financials

Ratios

Liquidity

Asset Efficiency

Liabilities

Valuation

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

Feedback

Request to add more info/data

Inform about wrong info/data

Signup to access all features and start your US investing journey!

Add ticker to compare

Popular US Stocks 1

Popular US ETFs 2

Curated Portfolios (Vests)

52-week Range
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

Popular US Stocks ¹

Popular US ETFs ²